Your browser doesn't support javascript.
A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
Liu, Mei-Qin; Lin, Hao-Feng; Li, Jing; Chen, Ying; Luo, Yun; Zhang, Wei; Hu, Ben; Tian, Feng-Juan; Hu, Yun-Jia; Liu, Yu-Jie; Jiang, Ren-Di; Gong, Qian-Chun; Li, Ang; Guo, Zi-Shuo; Li, Bei; Yang, Xing-Lou; Tong, Yi-Gang; Shi, Zheng-Li.
  • Liu MQ; CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People's Republic of China.
  • Lin HF; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Li J; CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People's Republic of China.
  • Chen Y; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Luo Y; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Zhang W; CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People's Republic of China.
  • Hu B; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Tian FJ; CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People's Republic of China.
  • Hu YJ; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
  • Liu YJ; CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People's Republic of China.
  • Jiang RD; CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People's Republic of China.
  • Gong QC; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Li A; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Guo ZS; College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
  • Li B; State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.
  • Yang XL; State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.
  • Tong YG; CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People's Republic of China.
  • Shi ZL; University of Chinese Academy of Sciences, Beijing, People's Republic of China.
J Virol ; 97(2): e0171922, 2023 02 28.
Article in English | MEDLINE | ID: covidwho-2213880
ABSTRACT
Coronavirus disease 2019 (COVID-19), which is caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the most severe emerging infectious disease in the current century. The discovery of SARS-CoV-2-related coronaviruses (SARSr-CoV-2) in bats and pangolins in South Asian countries indicates that SARS-CoV-2 likely originated from wildlife. To date, two SARSr-CoV-2 strains have been isolated from pangolins seized in Guangxi and Guangdong by the customs agency of China, respectively. However, it remains unclear whether these viruses cause disease in animal models and whether they pose a transmission risk to humans. In this study, we investigated the biological features of a SARSr-CoV-2 strain isolated from a smuggled Malayan pangolin (Manis javanica) captured by the Guangxi customs agency, termed MpCoV-GX, in terms of receptor usage, cell tropism, and pathogenicity in wild-type BALB/c mice, human angiotensin-converting enzyme 2 (ACE2)-transgenic mice, and human ACE2 knock-in mice. We found that MpCoV-GX can utilize ACE2 from humans, pangolins, civets, bats, pigs, and mice for cell entry and infect cell lines derived from humans, monkeys, bats, minks, and pigs. The virus could infect three mouse models but showed limited pathogenicity, with mild peribronchial and perivascular inflammatory cell infiltration observed in lungs. Our results suggest that this SARSr-CoV-2 virus from pangolins has the potential for interspecies infection, but its pathogenicity is mild in mice. Future surveillance among these wildlife hosts of SARSr-CoV-2 is needed to monitor variants that may have higher pathogenicity and higher spillover risk. IMPORTANCE SARS-CoV-2, which likely spilled over from wildlife, is the third highly pathogenic human coronavirus. Being highly transmissible, it is perpetuating a pandemic and continuously posing a severe threat to global public health. Several SARS-CoV-2-related coronaviruses (SARSr-CoV-2) in bats and pangolins have been identified since the SARS-CoV-2 outbreak. It is therefore important to assess their potential of crossing species barriers for better understanding of their risk of future emergence. In this work, we investigated the biological features and pathogenicity of a SARSr-CoV-2 strain isolated from a smuggled Malayan pangolin, named MpCoV-GX. We found that MpCoV-GX can utilize ACE2 from 7 species for cell entry and infect cell lines derived from a variety of mammalian species. MpCoV-GX can infect mice expressing human ACE2 without causing severe disease. These findings suggest the potential of cross-species transmission of MpCoV-GX, and highlight the need of further surveillance of SARSr-CoV-2 in pangolins and other potential animal hosts.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Host Specificity / Pangolins / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Variants Limits: Animals / Humans Country/Region as subject: Asia Language: English Journal: J Virol Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Host Specificity / Pangolins / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Variants Limits: Animals / Humans Country/Region as subject: Asia Language: English Journal: J Virol Year: 2023 Document Type: Article